Prevalence of Plasmid-Mediated Quinolone Resistance and Aminoglycoside Resistance Determinants among Carbapeneme Non-Susceptible Enterobacter cloacae

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Huang, Shifeng ^a   Dai, Wei ^a   Sun, Shan ^a   Zhang, Xiaojiao ^a   Zhang, Liping ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZTREONAM; BETA LACTAMASE; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM; CEFAZOLIN; CEFEPIME; CEFOTETAN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TOBRAMYCIN;

AAC (6')LB CR GENE; AAC (6')LB GENE; ANTIBIOTIC RESISTANCE; ARMA GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA LACTAMASE CTX M GENE; BETA LACTAMASE KPC GENE; BETA LACTAMASE NDM GENE; BETA LACTAMASE SHV GENE; BETA LACTAMASE SME GENE; BETA LACTAMASE TEM GENE; BETA LACTAMASE VIM GENE; CONTROLLED STUDY; ENTEROBACTER CLOACAE; GENE EXPRESSION; GENE IDENTIFICATION; MOLECULAR CLONING; MOLECULAR DYNAMICS; MOLECULAR EPIDEMIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; QNRA GENE; QNRB GENE; QNRS GENE; RMTB GENE; SEQUENCE ANALYSIS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTER CLOACAE; PLASMIDS; QUINOLONES;

EID: 84867887933     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047636     Document Type: Article

References (30)

1. Yang FC, Yan JJ, Hung KH, Wu JJ, (2012) Characterization of Ertapenem-resistant Enterobacter cloacae in a Taiwanese University Hospital. J Clin Microbiol 50: 223-226.
2. Bush K, (2010) Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol 13: 558-564.
3. Paterson DL, Bonomo RA, (2005) Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
4. Cornaglia G, Giamarellou H, Rossolini GM, (2011) Metallo-β-lactamases: a last frontier for β-lactams? Lancet Infect Dis11: 381-393.
5. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, et al. (2010) Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16: 112-122.
6. Naas T, Cuzon G, Bogaerts P, Glupczynski Y, Nordmann P, (2011) Evaluation of a DNA Microarray (Check-MDR CT102) for Rapid Detection of TEM, SHV, and CTX-M Extended-Spectrum β-Lactamases and of KPC, OXA-48, VIM, IMP, and NDM-1 Carbapenemases. J Clin Microbiol 49: 1608-1613.
7. Paterson DL, (2000) Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs). Clin Microbiol Infect 6: 460-463.
8. Patrick MG, Jun H, Robert JC, Yu Y, Yoon IK, et al. (2012) Complete Sequence of a Novel 178-Kilobase Plasmid Carrying blaNDM-1 in a Providencia stuartii Strain Isolated in Afghanistan. Antimicrob Agents Chemother 56: 1673-1679.
9. Mammeri H, Van De Loo M, Poirel L, Martinez-Martinez L, Nordmann P, (2005) Emergence of plasmid-mediated quinolone resistance in Escherichia coli in Europe. Antimicrob Agents Chemother 49: 71-76.
10. Johann D-DP, Patrice N, Kevin BL, Laurent P, (2005) Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. Antimicrob Chemother 56: 52-59.
11. Strahilevitz J, Jacoby GA, Hooper DC, Robicsek A, (2009) Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin Microbiol Rev 22: 664-689.
12. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, et al. (2006) Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12: 83-88.
13. Cano LM-M, Pascual A, (2007) Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1. Antimicrob Agents Chemother 51: 2236-2239.
14. Strahilevitz J, Engelstein D, Adler A, Temper V, Moses AE, et al. (2007) Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005. Antimicrob Agents Chemother 51: 3001-3003.
15. Robicsek A, Jacoby GA, Hooper DC, (2006) The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect Dis 6: 629-640.
16. Wu JJ, Ko WC, Tsai SH, Yan JJ, (2007) Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwanese hospital. Antimicrob Agents Chemother 51: 1223-1227.
17. Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y, (2008) Plasmid-Mediated qnrB2 and Carbapenemase Gene blaKPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates. Antimicrob Agents Chemother 52: 2962-2965.
18. O'Neill AJ, (2008) New antibacterial agents for treating infections caused by multi-drug resistant Gram-negative bacteria. Expert Opin Investig Drugs 17: 297-302.
19. Folster JP, Rickert R, Barzilay EJ, Whichard JM, (2009) Identification of the Aminoglycoside Resistance Determinants armA and rmtC among Non-Typhi Salmonella Isolates from Humans in the United States. Antimicrob Agents Chemother 53: 4563-4564.
20. Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, et al. (2009) Widespread Dissemination of Aminoglycoside Resistance Genes armA and rmtB in Klebsiella pneumoniae Isolates in Taiwan Producing CTX-M-Type Extended-Spectrum β-Lactamases. Antimicrob Agents Chemother 53: 104-111.
21. Poirel L, Dortet L, Bernabeu, Nordmann P, (2011) Genetic Features of blaNDM-1-Positive Enterobacteriaceae. Antimicrob Agents Chemother 55: 5403-5407.
22. Liu Y, Zhang B, Cao Q, Huang WC, Shen LS, et al. (2009) Two Clinical Strains of Klebsiella pneumoniae Carrying Plasmid-Borne blaIMP-4, blaSHV-12, and armA Isolated at a Pediatric Center in Shanghai, China. Antimicrob Agents Chemother 53: 1642-1644.
23. Zacharczuk K, Piekarska K, Szych J, Zawidzka E, Sulikowska A, et al. (2011) Emergence of Klebsiella pneumoniae Coproducing KPC-2 and 16S rRNA Methylase ArmA in Poland. Antimicrob Agents Chemother 55: 443-446.
24. Yang H, Chen H, Yang Q, Chen M, Wang H, (2008) High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6′)-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China. Antimicrob Agents Chemother 52: 4268-4273.
25. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
26. Kim HB, Park CH, Kim CJ, Kim EC, Jacoby GA, et al. (2009) Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period. Antimicrob Agents Chemother 53: 639-645.
27. Robicsek A, Strahilevitz J, Sahm DF, Jacoby GA, Hooper DC, (2006) qnr Prevalence in Ceftazidime-Resistant Enterobacteriaceae Isolates from the United States. Antimicrob Agents Chemother 50: 2872-2874.
28. Livermore DM, Mushtaq S, Warner M, Zhang JC, Maharjan S, et al. (2011) Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 66: 48-53.
29. Vakulenko SB, Mobashery S, (2003) Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 16: 430-450.
30. Wu Q, Liu Q, Han L, Sun J, Ni Y, (2010) Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 and ArmA 16S rRNA methylase conferring high-level aminoglycoside resistance in carbapenem-resistant Enterobacter cloacae in China. Diagn Microbiol Infect Dis 66: 326-328.